Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
24 Oct 2018 Carboplatin Plus Paclitaxel Respresents a New Standard of Care for Patients with Squamous Cell Carcinoma of the Anal Canal Gastrointestinal cancers - Anticancer agents & Biologic therapy
22 Oct 2018 Alectinib Provides Superior Outcomes Compared with Crizotinib in Asian Patients with Advanced ALK-positive NSCLC, with and without CNS Metastases Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
22 Oct 2018 B-F1RST Study Evaluates Blood-Based Tumour Mutational Burden as a Biomarker of Atezolizumab Activity in First-Line NSCLC Treatment Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
22 Oct 2018 Optimal Neo-Adjuvant Combination of Ipilimumab and Nivolumab Devised in High Risk Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
21 Oct 2018 Entrectinib Is Effective Across NTRK Fusion Positive Solid Tumour Types Personalised medicine - Anticancer agents & Biologic therapy
20 Oct 2018 Cabozantinib Improves Survival Over Everolimus or Sunitinib in PD-L1 Unselected Patients with mRCC Genitourinary cancers - Anticancer agents & Biologic therapy
20 Oct 2018 Early Results From a Ground Breaking Study of Tumour Evolution Identifies Genetic Drivers in NSCLC Lung and other thoracic tumours - Translational research
20 Oct 2018 Molecular Characteristics of Clinical Response to Atezolizumab plus Bevacizumab Differ from Sunitinib in IMmotion151 Study Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
20 Oct 2018 Addition of Ipilimumab Improves Nivolumab Response in PD-L1 Unselected Patients with Platinum-Pretreated Metastatic Urothelial Cancer Genitourinary cancers - Cancer Immunology and Immunotherapy
20 Oct 2018 Immunotherapy May Be a New Treatment Option for Patients with Chemotherapy Resistant Gestational Trophoblastic Neoplasias Gynaecologic malignancies - Cancer Immunology and Immunotherapy
19 Oct 2018 First-in-Class NBTXR3 Provides a New Option for Preoperative Treatment in Patients with Locally Advanced STS (Act-In-Sarc) Sarcomas
19 Oct 2018 Patients with Lung Adenocarcinomas and Specific Uncommon EGFR Mutations Have Improved Survival with Chemotherapy Compared to TKIs Lung and other thoracic tumours - Anticancer agents & Biologic therapy
19 Oct 2018 Promising Anti-Tumour Activity Demonstrated with First-Line Nazartinib in Adult Patients with EGFR-Mutant NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
16 Oct 2018 ESMO Thanks Oncology Nurses for Their Outstanding Contribution in the Review of the Patient Guides
16 Oct 2018 Let’s Talk Women’s Cancers Breast cancer - Gynaecologic malignancies